Created in 1996 through the merger of Ciba-Geigy and Sandoz, Novartis is currently organized into four divisions. We are always strengthening our medicine-based portfolio, and investing in strategic growth platforms. And Novartis is the only company with leadership positions in both patented and generic pharmaceuticals.
